Resistance to antibiotics for H. pylori has more than doubled in 20 years, new research presented at UEG Week Barcelona 2019 has shown. The study analysed 1,232 patients from 18 countries across Europe, investigated resistance to antibiotics taken for Helicobacter pylori. Resistance to clarithromycin had increased from 9.9% in 1998 to 21.6% last year, with increases in resistance also seen for levofloxacin and metronidazole. With resistance rates to clarithromycin increasing at an alarming rate of nearly 1% per year, treatment options for H.
pylori will become progressively limited and ineffective. H. pylori is one of the most common bacterial infections in humans and are estimated to be present in one-half of the world's population. In 2017, the World Health Organisation identified clarithromycin-resistant H. pylori as a high priority bacterium for antibiotic research and development.…
